Emergent BioSolutions Inc. - Common Stock (EBS)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
54,486,781
Total 13F shares
53,110,910
Share change
-51,796
Total reported value
$4,155,188,937
Put/Call ratio
72%
Price per share
$79.08
Number of holders
292
Value change
-$1,228,124
Number of buys
155
Number of sells
127

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2020

As of 30 Jun 2020, Emergent BioSolutions Inc. - Common Stock (EBS) was held by 292 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,110,910 shares. The largest 10 holders included Copper Rock Capital Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, STATE STREET CORP, EARNEST PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, MANUFACTURERS LIFE INSURANCE COMPANY, THE, SNYDER CAPITAL MANAGEMENT L P, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 293 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.